Can Palm Reading Predict Your Health Future?

Hepatitis B is a viral infection that affects the liver and can cause both acute and chronic disease. The infection is transmitted through contact with infected blood or other body fluids. Laboratory testing plays a crucial role in diagnosing hepatitis B, monitoring the progression of the disease, and determining the appropriate treatment approach. Understanding the different hepatitis B markers and what they indicate helps healthcare providers make informed decisions about patient care.

The hepatitis B surface antigen, known as HBsAg, is typically the first marker to appear in the blood after infection. A positive HBsAg test indicates an active hepatitis B infection, whether acute or chronic. If this marker remains positive for more than six months, it suggests the infection has become chronic. The hepatitis B surface antibody, or anti-HBs, appears after the infection has cleared or following successful vaccination. A positive anti-HBs test indicates immunity to hepatitis B, either from recovery or vaccination. The hepatitis B core antibody comes in two forms: IgM anti-HBc, which appears during acute infection, and IgG anti-HBc, which remains detectable for life after exposure to the virus.

Additional tests help assess the level of viral activity and infectivity. The hepatitis B e antigen, or HBeAg, indicates active viral replication and high infectivity. When this marker disappears and the hepatitis B e antibody, or anti-HBe, appears, it usually means the virus is less active and the person is less infectious. The hepatitis B virus DNA test measures the actual amount of virus in the blood and is used to monitor disease activity and response to treatment. Liver function tests, including ALT and AST enzymes, help evaluate liver damage caused by the infection.

Interpreting hepatitis B test results requires looking at the combination of markers present. Someone who has never been infected or vaccinated will test negative for all markers. A person with acute infection will typically show positive HBsAg and IgM anti-HBc. Chronic infection is indicated by positive HBsAg lasting more than six months along with positive IgG anti-HBc. Immunity from vaccination shows only positive anti-HBs, while immunity from past infection shows positive anti-HBs and anti-HBc with negative HBsAg. Regular monitoring through these laboratory tests helps healthcare providers track disease progression, assess liver health, and determine when antiviral treatment may be necessary for those with chronic hepatitis B infection.